• CHMP issues positive opinion for AstraZeneca’s Fasenra Pen pharmaceutical-technology
    July 04, 2019
    The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for Fasenra Pen, a pre-filled, single-use auto-injector.
  • Imbruvica receives positive opinion from CHMP pharmaceutical-technology
    July 03, 2019
    The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the existing marketing authorisation (MA) for Janssen’s Imbruvica (ibrutinib) to include chronic lymphocytic leukaemia (CLL) and Waldenst
  • CHMP Issues Positive Opinion for Avelumab for Metastatic Merkel Cell Carcinoma americanpharmaceuticalreview
    July 24, 2017
    Merck and Pfizer announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of avelumab...
PharmaSources Customer Service